Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins

NCT01372631 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01372631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01372631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
April 1, 2017
Enrollment
218 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer